Literature DB >> 17470852

Successful treatment of leptomeningeal disease in colorectal cancer with a regimen of bevacizumab, temozolomide, and irinotecan.

Geoffrey Y Ku, George Krol, David H Ilson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17470852     DOI： 10.1200/JCO.2006.10.3317

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  9 in total

1.  Phase II trial of temozolomide for leptomeningeal metastases in patients with solid tumors.

Authors:  Pedro Pérez Segura; Miguel Gil; Carmen Balañá; Ignacio Chacón; José Muñoz Langa; María Martín; Jordi Bruna
Journal:  J Neurooncol       Date:  2012-05-20       Impact factor: 4.130

2.  Leptomeningeal metastasis as initial manifestation of signet ring colorectal adenocarcinoma: a case report with review of literature.

Authors:  Rita Assi; Lana Hamieh; Deborah Mukherji; Ali Haydar; Sally Temraz; Imane El-Dika; Ali Shamseddine
Journal:  J Gastrointest Oncol       Date:  2015-12

Review 3.  Novel approaches to treating leptomeningeal metastases.

Authors:  Jai Grewal; Marlon Garzo Saria; Santosh Kesari
Journal:  J Neurooncol       Date:  2011-08-28       Impact factor: 4.130

4.  Glioma-associated endothelial cells are chemoresistant to temozolomide.

Authors:  Jenilyn J Virrey; Encouse B Golden; Walavan Sivakumar; Weijun Wang; Ligaya Pen; Axel H Schönthal; Florence M Hofman; Thomas C Chen
Journal:  J Neurooncol       Date:  2009-04-18       Impact factor: 4.130

5.  Dose-Dense Temozolomide in Patients with MGMT-Silenced Chemorefractory Colorectal Cancer.

Authors:  Filippo Pietrantonio; Filippo de Braud; Massimo Milione; Claudia Maggi; Roberto Iacovelli; Katia Fiorella Dotti; Federica Perrone; Elena Tamborini; Marta Caporale; Rosa Berenato; Giorgia Leone; Alessio Pellegrinelli; Ilaria Bossi; Fabrizio Festinese; Stefano Federici; Maria Di Bartolomeo
Journal:  Target Oncol       Date:  2016-06       Impact factor: 4.493

6.  A pilot study of bevacizumab combined with etoposide and cisplatin in breast cancer patients with leptomeningeal carcinomatosis.

Authors:  Pei-Fang Wu; Ching-Hung Lin; Ching-Hua Kuo; Wei-Wu Chen; Dah-Cherng Yeh; Hsiao-Wei Liao; Shu-Min Huang; Ann-Lii Cheng; Yen-Shen Lu
Journal:  BMC Cancer       Date:  2015-04-17       Impact factor: 4.430

7.  Efficacy of temozolomide and bevacizumab for the treatment of leptomeningeal dissemination of recurrent glioblastoma: A case report.

Authors:  Yoshiko Okita; Masahiro Nonaka; Toru Umehara; Yonehiro Kanemura; Yoshinori Kodama; Masayuki Mano; Shin Nakajima
Journal:  Oncol Lett       Date:  2015-02-06       Impact factor: 2.967

Review 8.  Leptomeningeal disease: current diagnostic and therapeutic strategies.

Authors:  Gautam Nayar; Tiffany Ejikeme; Pakawat Chongsathidkiet; Aladine A Elsamadicy; Kimberly L Blackwell; Jeffrey M Clarke; Shivanand P Lad; Peter E Fecci
Journal:  Oncotarget       Date:  2017-08-16

9.  Neoplastic meningitis from solid tumors: a prospective clinical study in lombardia and a literature review on therapeutic approaches.

Authors:  A Silvani; M Caroli; P Gaviani; V Fetoni; R Merli; M Riva; M De Rossi; F Imbesi; A Salmaggi
Journal:  J Drug Deliv       Date:  2013-01-16
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.